About NADify

We have an opioid overdose epidemic. More than one million people have died since 1991 from a drug overdose. More than 75% of drug overdose deaths in 2021 involved an opioid. Synthetic opioids, like Fentanyl are making the situation that much worse.

The only way out is a detoxification process that involves dangerous withdrawal symptoms including seizures, vomiting, diarrhea, nausea, cramps, muscle pains, and sometimes death.

NADify is a game-changing holistic formula for the elimination of adverse opioid detoxification (withdrawal) symptoms. This product will provide a potentially life-saving benefit to those struggling with opioid addiction.

It is based on NAD (Nicotinamide adenine dinucleotide), a naturally occurring complex coenzyme which is present in every cell of your body. It is an essential part of healthy cellular metabolism. One of its functions is assisting in the removal of toxins and metabolic waste products.

Doctors have discovered that it can be used to virtually eliminate the adverse symptoms of the opioid detoxification process, which is to say that, with NAD treatment, people can get off those drugs without the terrible withdrawal symptoms we have all come to accept as the norm.

The current state of the art is a therapy which uses intravenous drips to provide the additional NAD. This requires that the patient sit still with a needle in their arm for eight to ten hours at a time. Full treatment requires them to do this for ten days (five days on, a two day break, then five days on again). This is considered alternative medicine as it does not utilize pharmaceutical products. While well-proven, most mainstream doctors are not yet familiar with it.

The NADify company produces an innovative NAD-based formula that provides essentially symptom-free opioid detoxification without needing needles or medical professionals to administer it.

The formula works by being breathed in, using a nebulizer, rather than being injected. The process only takes two hours per day for the same ten days. With just a bit of orientation, it can be easily administered by the patient themself.

NADify is not operating or selling product yet. We expect to be by the end of the year.